Malhotra A et al., SURMOUNT-OSA, NEJM 2024 (NEJMoa2404881, PMID 38912654) : tirzepatide and obstructive sleep apnea, AHI -25,3 to 52 weeks
This association has been observed for many years in other clinical studies looking at other methods of tightening blood sugar, but for most people, the risks are manageable by seeing a retina specialist well versed in treating diabetic eye disease
Currently, the FDA has officially approved a higher-dose formulation of semaglutide called Wegovy specifically for chronic weight management in adults who are overweight or obese, even if they do not have diabetes
Continue reading Which GLP-1 drug is best for weight loss
Discussing needle preferences with a PlexusDx care team member helps identify the specific combination that balances efficacy with minimal discomfort